About Index Trending news
Analyze
Pricing
Esperance Pharmaceuticals

Esperance Pharmaceuticals

Work at Esperance Pharmaceuticals? Add yourself to this profile

Esperance Pharmaceuticals

Esperance Pharmaceuticals develops anticancer drugs that kill cancer cells without harming normal cells.
Edit Profile
More info

Elsewhere

Companies in the same industry

Alimera Sciences Alimera Sciences KannaLife Sciences KannaLife Sciences Aerie Pharmaceuticals Aerie Pharmaceuticals Cellectis Cellectis molecular assemblies molecular assemblies Hyasynth Bio Hyasynth Bio Chantest Chantest FlowMetric FlowMetric Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc. AFFiRiS AG AFFiRiS AG

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
Latest funding
Venture capital (Series C)
$40,000,000
Employees

Team size

10+
Locations
HQ
United States
Headquarters
$40,000,000 Venture capital (Series C)
Xconomy

Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push

Health Science Funding
Esperance Pharmaceuticals
Esperance Pharmaceuticals